Neurogene Inc. (NGNE)
16.34
-1.35 (-7.63%)
At close: Mar 03, 2025, 3:59 PM
16.21
-0.77%
After-hours: Mar 03, 2025, 04:00 PM EST
Neurogene Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -36.32M | -55.19M | -50.52M | -33.28M | -69.44M | -31.59M | -50.18M | -37M | -21.86M | -23.82M | -8.73M | -7.71M | -10.51M |
| Depreciation & Amortization | 3.3M | 3.2M | 947K | 1.82M | 340K | n/a | n/a | n/a | n/a | 135.95K | 59.57K | 130.78K | 125.6K |
| Stock-Based Compensation | 1.42M | 1.25M | 896K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -4.69M | 912K | -1.39M | 966K | -2.24M | -5.43M | 917K | 4.71M | -580K | 20.23K | -102.79K | -12.08K | 3.86K |
| Other Non-Cash Items | -15.69M | 608K | 679K | 9.56M | 56.05M | 5.44M | 4.55M | 2.07M | 2.14M | 2.28M | -346.21K | 396.77K | 163.57K |
| Deferred Income Tax | -105K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.02M | -2.69M | 1.59M | 966K | -1.95M | -5.43M | 917K | 4.71M | -546K | 3.6M | 1.08M | -45.56K | 419.54K |
| Operating Cash Flow | -51.42M | -52.82M | -46.4M | -24.57M | -15.39M | -31.58M | -44.72M | -30.23M | -20.27M | -17.81M | -7.94M | -7.23M | -9.8M |
| Capital Expenditures | -321K | -2.23M | -18.37M | -2.22M | -879K | -49K | -494K | -713K | -27K | -113.89K | -11.75K | -6.45K | -62.85K |
| Acquisitions | n/a | n/a | n/a | n/a | 191K | n/a | n/a | n/a | 1K | 25.89K | 191.82K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -6M | -106.44M | -60.7M | -36.47M | -2.82M | n/a | n/a |
| Sales Maturities Of Investments | 5M | n/a | n/a | n/a | n/a | 56M | 70.5M | 59.1M | 13.2M | 12.99M | n/a | n/a | n/a |
| Other Investing Acitivies | 20.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 25.64M | -2.23M | -18.37M | -2.22M | -688K | 55.95M | 64.01M | -48.06M | -47.53M | -23.57M | -2.64M | -6.45K | -62.84K |
| Debt Repayment | -29K | -1K | n/a | -49K | -9K | -32K | -15K | -4K | n/a | -2.6M | 2.39M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 168K | 66.53M | 51.06M | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | -587.44K | n/a | n/a |
| Financial Cash Flow | 92.48M | 66.53M | 51.06M | 77.14M | 82.24M | 570K | 423K | 71.11M | 92.95M | 45.28M | 19.58M | n/a | 12.12M |
| Net Cash Flow | 66.7M | 11.48M | -13.71M | 49.46M | 66.17M | 24.9M | 19.73M | -7.17M | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | -51.74M | -55.05M | -64.77M | -26.79M | -16.27M | -31.63M | -45.21M | -30.94M | -20.3M | -17.92M | -7.95M | -7.24M | -9.86M |